Source: Health Canada shortage reports · Updated Jul 29, 2026
Some Glycopyrrolate products are in shortage in Canada (1 of 7 reported products), while others remain available. Your pharmacy may be able to substitute an unaffected manufacturer. The latest estimate for affected products to return is Aug 24, 2026.
An anticholinergic used to reduce saliva and airway secretions and, in inhalers, to treat COPD.
Products affected
1 / 7
In shortage since
May 1, 2026
Est. full return
Aug 24, 2026
Reports on file
26
Talk to a pharmacist
Pharmacists can substitute an unaffected manufacturer's version, adjust strengths, and in most provinces adapt or renew a prescription on the spot.
Independent services, not affiliated with rxstat; referral fees may apply. Free options exist depending on your province. In an emergency call 911; free health advice at 811.
Shortage history
Shortage history (red bands = periods in shortage).
Reports by product
The DIN is printed on your prescription label.
Active shortage
GLYCOPYRROLATE INJECTION
0.2MG · LIQUID · OMEGA LABORATORIES LIMITED
DIN 02382857 · since May 1, 2026, est. end Aug 24, 2026 · Disruption of the manufacture of the drug.
Resolved
GLYCOPYRROLATE INJECTION USP
4MG · SOLUTION · STERIMAX INC
DIN 02473887 · ended May 27, 2026 · Delay in shipping of the drug.
Resolved
GLYCOPYRROLATE INJECTION USP
0.2MG · SOLUTION · JAMP PHARMA CORPORATION
DIN 02532379 · ended Apr 10, 2026 · Disruption of the manufacture of the drug.
Resolved
GLYCOPYRROLATE INJECTION USP
0.2MG · SOLUTION · SANDOZ CANADA INCORPORATED
DIN 02039508 · ended Mar 30, 2026 · Demand increase for the drug.
Resolved
GLYCOPYRROLATE INJECTION USP
0.4MG · SOLUTION · STERIMAX INC
DIN 02473895 · ended Mar 11, 2026 · Demand increase for the drug.
Resolved
GLYCOPYRROLATE INJECTION USP
0.2MG · SOLUTION · STERIMAX INC
DIN 02473879 · ended Mar 11, 2026 · Delay in shipping of the drug.
Resolved
GLYCOPYRROLATE INJECTION
0.2MG · LIQUID · OMEGA LABORATORIES LIMITED
DIN 02382857 · ended Feb 17, 2026 · Demand increase for the drug.
Resolved
GLYCOPYRROLATE INJECTION
0.2MG · LIQUID · OMEGA LABORATORIES LIMITED
DIN 02382857 · ended Nov 8, 2025 · Demand increase for the drug.
Resolved
GLYCOPYRROLATE INJECTION USP
0.4MG · SOLUTION · STERIMAX INC
DIN 02473895 · ended Sep 15, 2025 · Requirements related to complying with good manufacturing practices.
Resolved
GLYCOPYRROLATE INJECTION USP
4MG · SOLUTION · STERIMAX INC
DIN 02473887 · ended Sep 15, 2025 · Requirements related to complying with good manufacturing practices.
Resolved
GLYCOPYRROLATE INJECTION
0.2MG · LIQUID · OMEGA LABORATORIES LIMITED
DIN 02382857 · ended Jul 31, 2025 · Delay in shipping of the drug.
Resolved
GLYCOPYRROLATE INJECTION USP
0.2MG · SOLUTION · SANDOZ CANADA INCORPORATED
DIN 02039508 · ended Dec 4, 2023 · Disruption of the manufacture of the drug.
Showing 12 of 26 reports. All reports are on file with Health Canada.
What's happening
Glycopyrrolate is currently affected by an active shortage report filed with Health Canada by OMEGA LABORATORIES LIMITED.
The reported cause is: disruption of the manufacture of the drug. Manufacturers must report shortages, but end-date estimates are their own projections and often move.
If your usual product is affected, a pharmacist is the fastest route to a solution: they can dispense an unaffected manufacturer's equivalent when one exists, and in most provinces can adapt doses or substitute a therapeutic alternative without a new appointment.
Glycopyrrolate is classified under “DRUGS FOR FUNCTIONAL BOWEL DISORDERS” (ATC A03AB).
Recent changes
Jul 29, 2026
Estimated end date pushed back : Aug 21, 2026 → Aug 24, 2026
Common questions
What is Glycopyrrolate used for?
An anticholinergic used to reduce saliva and airway secretions and, in inhalers, to treat COPD.
When will Glycopyrrolate be back in stock in Canada?
The latest manufacturer estimate is Aug 24, 2026. Estimates are self-reported and often slip; this page updates automatically when they change.
Why is Glycopyrrolate in shortage?
See the reports above; manufacturers must state a reason (most commonly manufacturing disruption or a surge in demand) when filing with Health Canada.
What can my pharmacist do about it?
Often quite a lot: substitute an equivalent product from an unaffected manufacturer, adjust quantities, or in most provinces adapt or renew prescriptions on the spot. Call your pharmacy before visiting, and call 811 for free health advice.
Email alerts
Get an email when this drug's status changes. Double opt-in, one-click unsubscribe.
Drugs in the same therapeutic class, best-supplied first. These are not automatic substitutes: only your pharmacist or prescriber can judge whether a switch makes sense for you.
Data reflects reports manufacturers are legally required to file with Health Canada, republished with per-drug aggregation by rxstat. Estimated end dates are supplied by manufacturers and frequently change. This page describes drug supply only and is not medical advice; never stop or switch a medication without speaking to your pharmacist or prescriber.